Outcomes selected to administer MTM program for employees in the State of Iowa

NewsGuard 100/100 Score

Outcomes Pharmaceutical Health Care® (Outcomes®) has been selected by the State of Iowa Department of Administrative Services to administer a Medication Therapy Management (MTM) program for the state employee health plan.

“Medication Therapy Management is about strong public-private partnerships that save taxpayer money and improves the quality of life of state employees. A win-win if I ever saw one”

Under the program, State of Iowa employees and dependents will be eligible to receive MTM services to help them achieve safe and effective results from their medications. It is anticipated over 64,000 patients will be enrolled across Iowa.

"Medication Therapy Management is about strong public-private partnerships that save taxpayer money and improves the quality of life of state employees. A win-win if I ever saw one," said Iowa Senator Jeff Danielson (D - Cedar Falls), who championed legislation for the program.

Among the services available is an annual Comprehensive Medication Review, which allows patients to meet one-on-one with a specially-trained pharmacist or other qualified health care provider in their area. The pharmacist will review the patient's complete medication profile to detect any potential conflicts or duplications and work with area doctors to optimize each patient's medication regimen. Other covered services include Prescriber Consultations, Patient Education & Monitoring and Patient Compliance Consultations.

Source:

Outcomes Pharmaceutical Health Care

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lancet Commission predicts sharp increase in global prostate cancer cases